Daniel P. Dolan
YOU?
Author Swipe
View article: 949 ‘Host Stage Migration’ in Newly Diagnosed, Operable Colorectal Cancer During the First Wave of the COVID-19 Pandemic – A Multicentre Comparative Cohort Study
949 ‘Host Stage Migration’ in Newly Diagnosed, Operable Colorectal Cancer During the First Wave of the COVID-19 Pandemic – A Multicentre Comparative Cohort Study Open
Aim The COVID-19 pandemic caused immeasurable disruption to cancer pathways across the United Kingdom, resulting in many patients presenting with more advanced stages of disease. This study explores whether migration of ‘host-stage’ was ev…
View article: Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution
Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution Open
Surgical wait time, pathologic tumor size, and complications were not different among patients undergoing surgery before vs. during the pandemic. Importantly, no patients became infected as a result of their hospital stay. The significant …
View article: How I do it: Multiport video-assisted thoracoscopic surgery of the right middle lobe for non–small cell lung cancer: Right middle lobectomy in 12 steps
How I do it: Multiport video-assisted thoracoscopic surgery of the right middle lobe for non–small cell lung cancer: Right middle lobectomy in 12 steps Open
Central MessageMultiport video-assisted thoracoscopic surgery: lobectomy of the right middle lobe for non–small cell lung cancer as demonstrated by Dr Scott J. Swanson.See Commentary on page 136. Multiport video-assisted thoracoscopic surg…
View article: Risk factors for prolonged air leak and need for intervention following lung resection
Risk factors for prolonged air leak and need for intervention following lung resection Open
OBJECTIVES Prolonged air leak (PAL; >5 days) following lung resection is associated with postoperative morbidity. We investigated factors associated with PAL and PAL requiring intervention. METHODS Retrospective review of all patients u…
View article: Introduction to current challenges in thoracic surgery special series: how to evaluate, diagnose and treat small lung nodules
Introduction to current challenges in thoracic surgery special series: how to evaluate, diagnose and treat small lung nodules Open
Introduction to current challenges in thoracic surgery special series: how to evaluate, diagnose and treat small lung nodules With increased imaging of the chest being done for a variety of non-lung cancer reasons and possible changes in e…
View article: Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes
Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes Open
OBJECTIVES Recent trials have begun to explore immune checkpoint inhibitors for non-small cell lung cancer in the neoadjuvant setting, but data on tumour response and surgical outcome remain limited. METHODS Retrospective evaluation of cli…
View article: The modern approach to esophagectomy—review of the shift towards minimally invasive surgery
The modern approach to esophagectomy—review of the shift towards minimally invasive surgery Open
The treatment of esophageal cancer has significantly advanced in the last 10 years and now includes multimodal treatment with a continued emphasis on surgical management. Minimally invasive esophagectomy (MIE) has been performed for almost…
View article: Sublobar resection in high-risk patients for lobectomy: current and future strategy
Sublobar resection in high-risk patients for lobectomy: current and future strategy Open
Surgical resection by lobectomy is the gold standard of therapy for early stage non-small cell lung cancer. However, not all patients are medically fit to undergo surgery. In patients considered high-risk for lobectomy, alternative strateg…
View article: Current state of minimally invasive treatment of locally advanced non-small cell lung cancer
Current state of minimally invasive treatment of locally advanced non-small cell lung cancer Open
Locally advanced non-small cell lung cancer (NSCLC) has historically been defined as Stage III by the IASCLC staging. While the workup for these patients has been standardized, the treatment algorithms remain unclear. The use of neoadjuvan…